β-elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor β and induces sensitization to cisplatin

Oncology Reports

Volumn 26, Issue 2, 2011, Pages 405-413

  Zhu, Tingzhun ^a   Xu, Yinghui ^a   Dong, Bin ^a   Zhang, Jianing ^a   Wei, Zhenqing ^a   Xu, Yousong ^a   Yao, Yiqun ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

elemene; Cisplatin; Glia maturation factor ; Glioblastoma

Indexed keywords

BETA ELEMENE; CISPLATIN; GLIA MATURATION FACTOR; GLIA MATURATION FACTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CHEMOSENSITIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CISPLATIN; GLIA MATURATION FACTOR; GLIOBLASTOMA; HUMANS; MAP KINASE KINASE 3; MAP KINASE KINASE 6; MICE; MICE, NUDE; PHOSPHORYLATION; RATS; RNA, SMALL INTERFERING; SESQUITERPENES; SIGNAL TRANSDUCTION;

EID: 79958227120     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1276     Document Type: Article

References (47)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109, 2007.
2. Wen PY and Kesari S: Malignant gliomas in adults. N Engl J Med 359: 492-507, 2008.
3. Kang TY, Jin T, Elinzano H and Peereboom D: Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safety. J Neurooncol 89: 113-118, 2008.
4. Clarke J, Butowski N and Chang S: Recent advances in therapy for glioblastoma. Arch Neurol 67: 279-283, 2010.
5. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY and Olson JJ: Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193, 2010.
6. Chen SL, You J and Wang GJ: Supercritical fluid extraction of beta-elemene under lower pressure. Se Pu 19: 179-181, 2001.
7. Wang K, Li Z, Chen Y and Su C: The pharmacokinetics of a novel antitumor agent, beta-elemene, in Sprague-Dawley rats. Biopharm Drug Dispos 26: 301-307, 2005. (Pubitemid 41601264)
8. Wang G, Li X, Huang F, Zhao J, Ding H, Cunningham C, Coad JE, Flynn DC, Reed E and Li QQ: Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci 62: 881-893, 2005. (Pubitemid 40655635)
9. Li X, Wang G, Zhao J, Ding H, Cunningham C, Chen F, Flynn DC, Reed E and Li QQ: Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cell Mol Life Sci 62: 894-904, 2005. (Pubitemid 40655636)
10. Xu L, Tao S, Wang X, Yu Z, Wang M, Chen D, Jing Y and Dong J: The synthesis and anti-proliferative effects of beta-elemene derivatives with mTOR inhibition activity. Bioorg Med Chem 14: 5351-5356, 2006. (Pubitemid 43922417)
11. Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ and Xu YH: Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer Lett 264: 127-134, 2008. (Pubitemid 351602131)
12. Peng X, Zhao Y, Liang X, Wu L, Cui S, Guo A and Wang W: Assessing the quality of RCTs on the effect of beta-elemene, one ingredient of a Chinese herb, against malignant tumors. Contemp Clin Trials 27: 70-82, 2006. (Pubitemid 41758440)
13. Tao L, Zhou L, Zheng L and Yao M: Elemene displays anticancer ability on laryngeal cancer cells in vitro and in vivo. Cancer Chemother Pharmacol 58: 24-34, 2006.
14. Li QQ, Wang G, Huang F, Banda M and Reed E: Antineoplastic effect of beta-elemene on prostate cancer cells and other types of solid tumour cells. J Pharm Pharmacol 62: 1018-1027, 2010.
15. Zhu T, Zhao Y, Zhang J, Li L, Zou L, Yao Y and Xu Y: β-elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually compensatory activation of MKK3 and MKK6. Int J Oncol 38: 419-426, 2011.
16. Xu YH, Dong B, Luo QZ, Zhou HY, Jia YC, Yang YF and Wang YZ: Influence of elemene on the expression of Bcl-2 family genes in rat C6 glioma cells. Zhonghua Yi Xue Za Zhi 85: 1700-1703, 2005. (Pubitemid 41166897)
17. Yao YQ, Xu YH, Lu J, Zhou HY and Wang YZ: Effect of p38 MAPK on elemene-induced cell cycle arrest in C6 glioblastoma cells. Zhonghua Yi Xue Za Zhi 88: 56-58, 2008. (Pubitemid 351459712)
18. Tan P, Zhong W and Cai W: Clinical study on treatment of 40 cases of malignant brain tumor by elemene emulsion injection. Zhongguo Zhong Xi Yi Jie He Za Zhi 20: 645-648, 2000.
19. Zaheer A, Zaheer S, Sahu SK, Knight S, Khosravi H, Mathur SN and Lim R: A novel role of glia maturation factor: induction of granulocyte-macrophage colony-stimulating factor and proinflammatory cytokines. J Neurochem 101: 364-376, 2007. (Pubitemid 46525279)
20. Kaimori JY, Takenaka M, Nakajima H, Hamano T, Horio M, Sugaya T, Ito T, Hori M, Okubo K and Imai E: Induction of glia maturation factor-beta in proximal tubular cells leads to vulnerability to oxidative injury through the p38 pathway and changes in antioxidant enzyme activities. J Biol Chem 278: 33519-33527, 2003. (Pubitemid 37055806)
21. Lim R, Hicklin DJ, Ryken TC, Han XM, Liu KN, Miller JF and Baggenstoss BA: Suppression of glioma growth in vitro and in vivo by glia maturation factor. Cancer Res 46: 5241-5247, 1986. (Pubitemid 16008296)
22. Kang YJ, Seit-Nebi A, Davis RJ and Han J: Multiple activation mechanisms of p38alpha mitogen-activated protein kinase. J Biol Chem 281: 26225-26234, 2006. (Pubitemid 44401830)
23. Dérijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ and Davis RJ: Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267: 682-685, 1995.
24. Yao YQ, Xu YH, Zhou HY, Cui CZ and Wang YZ: Role of ERK in the inhibitory effects of elemene on the proliferation of rat C6 glioblastoma cells. Tumor 27: 777-779, 2007.
25. Zaheer A and Lim R: In vitro inhibition of MAP kinase (ERK1/ ERK2) activity by phosphorylated glia maturation factor (GMF). Biochemistry 35: 6283-6288, 1996.
26. Lim R and Zaheer A: In vitro enhancement of p38 mitogen-activated protein kinase activity by phosphorylated glia maturation factor. J Biol Chem 271: 22953-22956, 1996.
27. Baldwin RM, Garratt-Lalonde M, Parolin DA, Krzyzanowski PM, Andrade MA and Lorimer IA: Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling. Oncogene 25: 2909-2919, 2006. (Pubitemid 43739241)
28. Zaheer A, Zaheer S, Thangavel R, Wu Y, Sahu SK and Yang B: Glia maturation factor modulates beta-amyloid-induced glial activation, inflammatory cytokine/chemokine production and neuronal damage. Brain Res 1208: 192-203, 2008.
29. Zaheer A, Zaheer S, Sahu SK, Yang B and Lim R: Reduced severity of experimental autoimmune encephalomyelitis in GMF-deficient mice. Neurochem Res 32: 39-47, 2007. (Pubitemid 46023415)
30. Zaheer S, Wu Y, Bassett J, Yang B and Zaheer A: Glia maturation factor regulation of STAT expression: a novel mechanism in experimental autoimmune encephalomyelitis. Neurochem Res 32: 2123-2131, 2007. (Pubitemid 350059856)
31. Gandhi M, Smith BA, Bovellan M, Paavilainen V, Daugherty- Clarke K, Gelles J, Lappalainen P and Goode BL: GMF is a cofilin homolog that binds Arp2/3 complex to stimulate filament debranching and inhibit actin nucleation. Curr Biol 20: 861-867, 2010.
32. Zaheer A, Knight S, Zaheer A, Ahrens M, Sahu SK and Yang B: Glia maturation factor overexpression in neuroblastoma cells activates glycogen synthase kinase-3beta and caspase-3. Brain Res 1190: 206-214, 2008.
33. Lawrence MC, Jivan A, Shao C, Duan L, Goad D, Zaganjor E, Osborne J, McGlynn K, Stippec S, Earnest S, Chen W and Cobb MH: The roles of MAPKs in disease. Cell Res 8: 436-442, 2008. (Pubitemid 351498850)
34. Lee HY, Crawley S, Hokari R, Kwon S and Kim YS: Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/CREB, PI3K/Akt/IkappaB/NF-kappaB and p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1 pathway. Int J Oncol 36: 941-953, 2010.
35. Yang Z, Zhang X, Darrah PA and Mosser DM: The regulation of Th1 responses by the p38 MAPK. J Immunol 185: 6205-6213, 2010.
36. Kumar V, Behera R, Lohite K, Karnik S and Kundu GC: p38 kinase is crucial for osteopontin-induced furin expression that supports cervical cancer progression. Cancer Res 70: 10381-10391, 2010.
37. Son JK, Varadarajan S and Bratton SB: TRAIL-activated stress kinases suppress apoptosis through transcriptional upregulation of MCL-1. Cell Death Differ 17: 1288-1301, 2010.
38. Shin JS, Woo SH, Lee HC, Hong SW, Yoo DH, Hong SI, Lee WJ, Lee MS, Jin YW, An S, Jin DH and Park IC: Low doses of ionizing radiation suppress doxorubicin-induced senescence-like phenotypes by activation of ERK1/2 and suppression of p38 kinase in MCF7 human breast cancer cells. Int J Oncol 36: 1445-1452, 2010.
39. Terada Y, Nakashima O, Inoshita S, Kuwahara M, Sasaki S and Marumo F: Mitogen-activated protein kinase cascade and transcription factors: the opposite role of MKK3/6-p38K and MKK1-MAPK. Nephrol Dial Transplant 14 (Suppl 1): 45-47, 1999. (Pubitemid 29041837)
40. Chen JT, Fong YC, Li TM, Liu JF, Hsu CW, Chang CS and Tang CH: DDTD, an isoflavone derivative, induces cell apoptosis through the reactive oxygen species/apoptosis signal-regulating kinase 1 pathway in human osteosarcoma cells. Eur J Pharmacol 597: 19-26, 2008.
41. Cho SD, Ahn NS, Jung JW, Yang SR, Park JS, Lee YS, Jo EH, Hwang JW, Lii J and Kang KS: Critical role of the c-JunNH2- terminal kinase and p38 mitogen-activated protein kinase pathways on sodium butyrate-induced apoptosis in DU145 human prostate cancer cells. Eur J Cancer Prev 15: 57-63, 2006. (Pubitemid 43048744)
42. Liu AH, Deng P and Jiang Y: The TNF-alpha-induced apoptosis of LA795 cells is mediated by MAP kinase kinase 6. Zhonghua Jie He He Hu Xi Za Zhi 26: 88-92, 2003.
43. Habiro A, Tanno S, Koizumi K, Izawa T, Nakano Y, Osanai M, Mizukami Y, Okumura T and Kohgo Y: Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells. Biochem Biophys Res Commun 316: 71-77, 2004. (Pubitemid 38299130)
44. Zaheer A and Lim R: Protein kinase A (PKA)- and protein kinase C-phosphorylated glia maturation factor promotes the catalytic activity of PKA. J Biol Chem 272: 5183-5186, 1997. (Pubitemid 27090076)
45. Li QQ, Wing G, Reed E, Huang L and Cuff CF: Evaluation of cisplatin in combination with beta-elemene as a regimen for prostate cancer chemotherapy. Basic Clin Pharmacol Toxicol 107: 868-876, 2010.
46. Li QQ, Wang G, Zhang M, Cuff CF, Huang L and Reed E: beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemo sensitivity of lung tumor cells by triggering apoptosis. Oncol Rep 22: 161-170, 2009.
47. Tao L, Zhou L, Zheng LY and Yao M: Inhibition of eIF families expression and angiogenesis for human laryngeal carcinoma by elemene administration. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 40: 840-845, 2005.